"Applied to an independent dataset of 500,000 individuals in Finland, it showed that higher genetic vulnerability to ...

Satizabal is lead author of the study titled, "Leptin bioavailability and markers of brain atrophy and vascular injury in the middle age," published Aug. 12 in Alzheimer's & Dementia: The Journal ...

Vascular dementia can occur suddenly or may develop over months or years. Learn about symptoms, causes, stages, risk factors, treatments, and outlook.

Vascular dementia often happens after several small strokes or a major stroke, when your brain isn't getting enough blood, oxygen, or the nutrients it needs. Your symptoms may start slowly, or ...

MRI-based structural imaging has become an integral component of the clinical assessment of patients with suspected Alzheimer disease (AD), and atrophy of medial temporal structures is now ...

Leptin bioavailability and markers of brain atrophy and vascular injury in the middle age. Alzheimer's & Dementia , 2024; 20 (9): 5849 DOI: 10.1002/alz.13879 Cite This Page : ...

MRI (magnetic resonance imaging) is an incredible technique that was first used to scan patients in the 1970s and 1980s. It uses radio waves, giant magnets, and computational tools to visualize ...

Brain-imaging procedures doctors use to diagnose vascular dementia include magnetic resonance imaging (MRI) or a computerized tomography (CT) scan.

Imaging of the brain is helpful in making the diagnosis of vascular and other dementias, and may include CT and/or MRI, and possibly Doppler ultrasound of the arteries leading to the brain.

They’re improving our capacity to measure loss of brain cells as this loss is the root cause of many symptoms of dementia. Additionally, they’re developing novel methods to measure the changes in ...

Early diagnosis: A predictive model uses structural MRI data to diagnose Alzheimer’s disease, even before obvious shrinkage of the brain occurs. (Courtesy: Pexels/Anna Shvets) Alzheimer’s disease (AD) ...

Satizabal is lead author of the study titled, "Leptin bioavailability and markers of brain atrophy and vascular injury in the middle age," published Aug. 12 in Alzheimer's & Dementia: The Journal ...